22/02/2023
Zdravlje is pleased to announce that as of 10th February 2023, Dr Milan Popovic has joined our team as a Sales Manager. Milan will lead our Sales team and closely cooperate with Zdravlje Commercial team from our Belgrade Office.
Contact:+381 60 790 2200info@zdravlje.co.rs
News - Zdravlje - Page 2
18/01/2023
We are very proud to announce that our Chairman and Board Member, Mr. Levent Selamoglu has been appointed as Chairman of Afrigen Biologics. Afrigen is a leading biotechnology company based in Cape Town, South Africa.
27/12/2022
Zdravlje / Frontier Biopharma (“Frontier”) and Adalvo are pleased to announce their collaboration in several therapeutic areas for the markets of Central and Eastern Europe and the Balkans. Over the next months and years, this collaboration will extend Frontier’s commercial and therapeutic footprint with a basket of more than 30 molecules from Adalvo’s advanced development pipeline in high value chronic and niche areas, targeting early-launch and first-generic opportunities where available.
13/12/2022
We are proud to announce that Zdravlje Leskovac has received the Award for Successful Business in 2022 by the Chamber of Commerce and Industry of Serbia. At the Ceremony held on 9 December, the Chamber of Commerce and Industry of Serbia awarded the traditional Annual Awards to the most successful companies in Serbia...
29/09/2022
Zdravlje Leskovac participated for the first time on September 29. at the great “Serbia Business Run“ in Belgrade. This manifestation, which aims to promote healthy lifestyles and running as a great way of recreation for the modern working person, is a series of 5 km business races, which are held in the largest business centers of Serbia and represent the largest sports and corporate event in our country.
01/09/2022
Zdravlje is pleased to announce that as of 1st September 2022, Mr. Tsvetomir Yordanov has joined our senior management team as Group Business Development Director, directly reporting to Kiren Naidoo (CEO).
18/08/2022
We are pleased to announce that as of 16 August Zdravlje Pharmaceuticals (Bulgaria), a subsidiary of Zdravlje Leskovac, has received a Wholesale Distribution Authorization by the Bulgarian Drug Agency (BDA)....
17/08/2022
The Serbian Agency for Medicines (ALIMS) has approved on 02.08.2022 the Marketing Authorisation for Regkirona (regdanvimab) for Serbia with Zdravlje AD Leskovac as the Marketing Authorisation Holder....
09/08/2022
Zdravlje is pleased to announce that as of 1st August 2022, Mr. Milan Markicevic has joined our senior management team as Group Finance Director, directly reporting to Kiren Naidoo (CEO)....
17/03/2022
Zdravlje A.D. (Zdravlje) announces the signing of a license agreement with the Medicines Patent Pool (MPP) for a generic version of nirmatrelvir, the novel oral COVID-19 antiviral medicine (PF-07321332) developed by Pfizer, which is administered in combination with low dose ritonavir (PF-07321332; ritonavir).
Zdravlje
locations
Information
industrial